Health Care/Hospital
Origin Agritech GMO Corn Hybrid is the One and Only Triple Stack Trait Corn Selected for National Demo Plot, Being Grown There in Anticipation of 2023 Commercial Launch
BEIJING, April 11, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), announced today that its GMO corn hybrid is the one and only triple stacked trait corn selected for the national demo plot and is currently being grown there in anticipation of a 2023 commerci...
2023-04-11 20:45
1715
Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil
YANTAI, China, April 11, 2023 /PRNewswire/ -- Boan Biotech today announced that Brazil's Agência Nacional de Vigilância Sanitária (ANVISA) has accepted the company's Biologics License Application (BLA) for Boyounuo® (Bevacizumab Injection). Envisioned to be "a leading global biopharmaceutical co...
2023-04-11 20:19
2687
OnCusp Therapeutics Showcases Potent Anti-Tumor Activity of its CDH6 ADC at AACR Annual Meeting 2023
NEW YORK, April 11, 2023 /PRNewswire/ -- OnCusp Therapeutics, a global biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, today announced that the preclinical data on its lead program CUSP0...
2023-04-11 20:00
1279
ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors
SINGAPORE, April 11, 2023 /PRNewswire/ -- ACM Biolabs (FR0012596468 – ALSEN) a pioneering Singaporean-Swiss biotechnology company, which specializes in the development of targeted therapeutics for the prevention of multiple life-threatening diseases based on its proprietary ACM (Artificial Cell ...
2023-04-11 19:00
1890
Biosyngen received China NMPA IND approval for its T-cell redirection therapy targeting EBV-positive Lymphoma
GUANGZHOU, China, April 11, 2023 /PRNewswire/ -- April 7th, 2023, Biosyngen Pte Ltd (hereinafter as "Biosyngen") was granted IND approval by China NMPA for the company's first-in-class T-cell redirection therapy, it is an autologous T cell therapy for EBV-positive lymphoma. The principle of autol...
2023-04-11 18:09
2163
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
LEIDEN, Netherlands, April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib) to patients inthe United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only trea...
2023-04-11 13:00
1958
When Blood Is a New Alternative Medicine for Pain Relief at Chula Pain Clinic
BANGKOK, April 11, 2023 /PRNewswire/ -- Chula Medicine researchers have successfully published an article on the injection of patient's own platelets rich plasma into the shoulderligaments resulting in pain reduction, heal torn ligaments and restore torn muscles as an alternative to surgery while...
2023-04-11 09:00
1974
SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices
* 'Zero WiredTM' and 'Zero EarbudsTM' named 'Winners' in the healthcare category for outstanding product design * SK Biopharmaceuticals' wearable devices earn a global accolade once again following the CES® Innovation Awards SEOUL, South Korea, April 10, 2023 /PRNewswire/ -- SK Biopharmaceuti...
2023-04-11 08:00
1680
Smith+Nephew signs exclusive distribution agreement to bring unique NAVBIT SPRINT™ solution for accurate acetabular cup alignment to Japan
Small, disposable, compact and simple to use navigation tool offers surgeons speed and reliability without the financial burden of capital equipment LONDON, April 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an agreement with NAV...
2023-04-11 07:00
2818
Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate
MELBOURNE, Australia, April 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a Phase I study of TLX101 investigational therapy (4-L-[131I]...
2023-04-11 05:00
1953
Asieris' subsidiary makes significant progress in its commercialization strategy by obtaining the "Drug Distribution License"
SHANGHAI, April 10, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that its subsidiary, Hainan Yahong ph...
2023-04-10 20:18
1958
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES RESIDENCY AT JLABS @ SHANGHAI
SINGAPORE, April 10, 2023 /PRNewswire/ -- Respiree announced today that it has
become a resident ofJohnson & Johnson Innovation – JLABS @ Shanghai ('JLABS')
2023-04-10 20:10
2525
JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with Moderately or Severely Refractory Systemic Lupus Erythematosus
SHANGHAI, April 10, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that it has received the Investigational New Drug (IND) clearance from the Na...
2023-04-10 19:30
2738
HistoIndex embarks on partnership with VCU's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health in the study of liver diseases
Advancing ML/AI-based technology in the study of liver diseases by furthering strategic partnerships using a stain-free digital pathology system. SINGAPORE, April 10, 2023 /PRNewswire/ -- Virginia Commonwealth University's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health has annou...
2023-04-10 19:00
2203
Fit Hub Secures US$6.5M to Expand Tech-enabled Fitness Solutions in Indonesia
JAKARTA, Indonesia, April 10, 2023 /PRNewswire/ -- Indonesian fitness startup Fit Hub has successfully raised US$ 6.5 million to make health and wellness accessible to all Indonesians. The Company receivedUS$ 3 million in seed funding in early 2022 from Global Founders Capital, Trihill Capital, a...
2023-04-10 17:06
2627
GC Genome Announces Publication Demonstrating Feasibility of Liquid Biopsy Technology to Predict Radiation Therapy Response in Solid Tumors
YONGIN, South Korea, April 9, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a new study in Radiation Oncology Journal,which demonstrates the feasibility of cell-free DNA(cfDNA) monitoring to predict treatment response and detect min...
2023-04-10 11:39
1474
Asian Agri and Tanoto Foundation Sign Joint Agreement with Pelalawan District Government to Combat Stunting
PELALAWAN, Indonesia, April 10, 2023 /PRNewswire/ -- In support of the Indonesia government's efforts to combat stunting, Asian Agri and Tanoto Foundation signed a joint agreement with the Government of Pelalawan Regency,Riau Province. The agreement was signed by H. Nasarudin, Deputy Regent of ...
2023-04-10 10:21
1895
Chula Launches the Latest Parkinson's Gloves to Reduce Tremors
Doctors at King Chulalongkorn Memorial Hospital have developed lightweight and easy-to-use Parkinson's gloves that can automatically reduce tremors, allowing Parkinson's Disease patients to enjoy social life and reducing side effects from medication and risk from brain surgery. BANGKOK, April 10...
2023-04-10 09:30
2974
China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released
SHANGHAI, April 6, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the whole industry chain layout, announced its Nectin-4 targeted site-specific ADC asset (R&D code: 9MW2821) demonstrated promising clinical data. The preliminary data show positive therapeut...
2023-04-07 16:34
4211
Cooperation Agreement Concluded between BioKangtai and Biotis
-- Indicating Technology Transfer of the World's First Dual-carrier 13-valent Pneumococcal Conjugate Vaccine toIndonesia SHENZHEN, China, April 7, 2023 /PRNewswire/ -- On the morning of April 5, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as "BioMinhai"), a wholly-owned subsi...
2023-04-07 10:41
3551
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 316 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
13580
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9405
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
8925
